Collaborate with us
1. Proposers
Title
Forename
Surname
Company name
2. Rationale
What is the compound's mechanism of action?
What is the target treatable trait?
Note: if it is not a current trait within the trial, the group proposing the intervention need to provide estimate of frequency, clinical features, and outcomes of the trait in patients meeting the platform eligibility criteria.
Why, in your view, would the product have efficacy in patients with that target treatable trait?
3. Evidence
At what stage of development is the compound?
Evidence in critically ill adults?
Please Select
Yes
No
Unknown
Evidence in non-critically ill adults?
Please Select
Yes
No
Unknown
Is the product being tested in any other trials that are ongoing?
Please Select
Yes
No
Unknown
4. Pharmacology
Pharmacokinetics
Pharmacodynamics
Safety data
Key drug interactions
5. Dosing Information
What is the compound's route of administration?
What is the proposed dose?
Justification of proposed dosage schedule
6. Costs
Please describe the funding model
Funding to secure IMP for the duration of the trial?
Funding to perform platform level biological assessments?
7. References
Additional references
Submit
Should be Empty: